Physician profile
Amy E Porter
NPI 1720194079
$3,192.76
in general payments reported to CMS, 2019-2025
23 companies · $533 in 2025
The $533 reported for 2025 was more than what 82% of Obstetrics providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $303 · 2020: $37.09 · 2021: $12.31 · 2022: $875 · 2023: $677 · 2024: $756 · 2025: $533.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,885 · Education: $80.10.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,885.01 |
| Education | $80.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $403.42 | 2019-2024 | |
| Astellas Pharma US INC | $399.39 | 2019-2025 | Veozah |
| Mayne Pharma Commercial LLC | $351.31 | 2022-2025 | |
| Millicent US INC | $301.51 | 2023-2025 | Femring, Intrarosa, Femlyv |
| Abbvie INC. | $269.98 | 2019-2025 | |
| Sumitomo Pharma America, INC. | $248.01 | 2023-2025 | Myfembree, Gemtesa |
| Organon LLC | $207.13 | 2022-2025 | Nexplanon |
| Myovant Sciences INC. | $199.68 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $151.14 | 2022-2025 | |
| Therapeuticsmd, INC. | $137.56 | 2019-2022 | |
| Coopersurgical, INC. | $90.20 | 2019-2023 | Paragard T 380a |
| Sage Therapeutics, LLC | $89.99 | 2024-2025 | Zurzuvae |
| Exact Sciences Corporation | $79.41 | 2023-2025 | Cologuard Collection Kit |
| Vertical Pharmaceuticals, LLC | $48.94 | 2019 | |
| Mycovia Pharmaceuticals, INC. | $34.70 | 2022-2023 | Vivjoa |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $32.06 | 2024 | Aptima |
| Amag Pharmaceuticals, INC. | $31.89 | 2019 | |
| Becton, Dickinson and Company | $24.22 | 2019 | |
| Optumhealth Care Solutions, LLC | $23.69 | 2025 | Vivify Health Care Team Portal 001, Eitan Medical |
| Cepheid | $22.03 | 2025 | |
| Merck Sharp & Dohme LLC | $17.80 | 2019 | |
| Aesculap, INC. | $15.25 | 2019 | |
| Lupin INC. | $13.45 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Porter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.